David Quan, PharmD
Pharmacist
COO
Chancellor/EVC/FAS

Education & Training

Show all (2) Hide

• PHA Primary Practice Residency Pharmacy University of California, San Francisco 1992
• Residency School of Pharmacy University of California, San Francisco 1991

Interests

Show all (5) Hide

• Transplant
• hepatitis B infection
• critical care
• liver diseases
• hepatitis C infection

Publications (18)

Top publication keywords:
Hepatitis B, ChronicPharmacokineticsKidney Function TestsKidney Failure, ChronicHepatitis BNephrologyHepatitis B virusTacrolimusDrug MonitoringDrug TherapyChelating AgentsKidney TransplantationHyperkalemiaAntiviral AgentsSpecialties, Nursing

• Mismatched Postsurgical Opioid Prescription to Liver Transplant Patients: A Retrospective Cohort Study From a Single High-volume Transplant Center.
  Transplantation 2024 Chen VJ, Guan LS, Bokoch MP, Langnas E, Kothari R, Croci R, Campbell LJ, Quan D, Freise C, Guan Z
• Nirmatrelvir/ritonavir Use With Tacrolimus in Lung Transplant Recipients: A Single-center Case Series.
  Transplantation 2022 Dewey KW, Yen B, Lazo J, Seijo L, Jariwala R, Shah RJ, Quan D, Carpenter B, Paul Singer J, Breen K, Hays S, Florez R
• Mechanisms and management of drug-induced hyperkalemia in kidney transplant patients.
  Reviews in endocrine & metabolic disorders 2021 Rizk JG, Lazo JG, Quan D, Gabardi S, Rizk Y, Streja E, Kovesdy CP, Kalantar-Zadeh K
• Standardizing Discharge Opioid Prescriptions in Kidney Transplant Patients Decreases Opioid Usage.
  The Journal of surgical research 2021 Schwab ME, Braun HJ, Quan D, Roll GR, Budanova N, Ascher NL, Hirose R
• Novel approaches to management of hyperkalaemia in kidney transplantation.
  Current opinion in nephrology and hypertension 2021 Rizk J, Quan D, Gabardi S, Rizk Y, Kalantar-Zadeh K

Show all (13 more) Hide

• Short Course of Postoperative Hepatitis B Immunoglobulin Plus Antivirals Prevents Reinfection of Liver Transplant Recipients.
  Transplantation 2017 Radhakrishnan K, Chi A, Quan DJ, Roberts JP, Terrault NA
• Impact of a pharmacist-driven protocol to improve drug allergy documentation at a university hospital.
  Hospital pharmacy 2013 Burrell C, Tsourounis C, Quan D, Jue V, Tam E, Guglielmo BJ
• Use of rifabutin for the treatment of a latent tuberculosis infection in a patient after solid organ transplantation.
  Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2013 Hickey MD, Quan DJ, Chin-Hong PV, Roberts JP
• Appropriately assessing renal function for drug dosing.
  Nephrology nursing journal : journal of the American Nephrology Nurses' Association 2010 Dong K, Quan DJ
• Pharmacotherapy of hepatitis C virus infection: a brief review.
  Nephrology nursing journal : journal of the American Nephrology Nurses' Association 2009 Quan DJ
• A brief history in nephrology pharmacotherapy.
  Nephrology nursing journal : journal of the American Nephrology Nurses' Association 2009 Quan DJ
• Pharmacotherapy of hepatitis B infection: a brief review.
  Nephrology nursing journal : journal of the American Nephrology Nurses' Association 2008 Quan DJ
• A primer on pharmacokinetics.
  Nephrology nursing journal : journal of the American Nephrology Nurses' Association 2008 Quan DJ
• Recombinant factor VIIa reduces transfusion requirements in liver transplant patients with high MELD scores.
  Transfusion medicine (Oxford, England) 2006 Niemann CU, Behrends M, Quan D, Eilers H, Gropper MA, Roberts JP, Hirose R
• Antiviral therapy: nucleotide and nucleoside analogs.
  Clinics in liver disease 2004 Quan DJ, Peters MG
• Severe liver injury after treatment with the leukotriene receptor antagonist zafirlukast.
  Annals of internal medicine 2000 Reinus JF, Persky S, Burkiewicz JS, Quan D, Bass NM, Davern TJ
• Experience with the use of sirolimus in liver transplantation--use in patients for whom calcineurin inhibitors are contraindicated.
  Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2000 Chang GJ, Mahanty HD, Quan D, Freise CE, Ascher NL, Roberts JP, Stock PG, Hirose R
• Experience with daclizumab in liver transplantation: renal transplant dosing without calcineurin inhibitors is insufficient to prevent acute rejection in liver transplantation.
  Transplantation 2000 Hirose R, Roberts JP, Quan D, Osorio RW, Freise C, Ascher NL, Stock PG